Tricia Schumann Rakusin

Tricia Schumann Rakusin is an accomplished professional with extensive experience in the healthcare and biotechnology sectors. Currently serving as Principal at Health Innovation Capital, an impact-driven venture capital firm focused on pediatric innovation, Tricia also contributes as a Board Member for CommonSpirit Health, one of the largest nonprofit health systems in the United States. Previous roles include Chief Investment Officer at MedTherapy Biotech, which specializes in accessible cancer therapies, and various board positions with organizations such as Orriant, Steward Health Care, and BioCorRx Pharmaceuticals Inc. Tricia's educational background includes advanced studies at Harvard Business School, Harvard Medical School, Columbia Business School, and the Massachusetts Institute of Technology, emphasizing management and medical fundamentals.